India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Approval based on results from T2NOW, one of the largest paediatric type-2 diabetes Phase III trials to date
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
EDQM has also issued a Certificate of Suitability for Allopurino
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
Sleep disturbances are among the most frequent and disruptive symptoms associated with menopause which can impact women’s health and quality of life
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
Bemdaneprocel is the most clinically advanced investigational cell therapy in the U.S. for treating patients living with Parkinson’s disease
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
Subscribe To Our Newsletter & Stay Updated
